Viaken and InforSense deliver enterprise data mining systems to life science companiesCopenhagen 23 July 2001 Viaken and InforSense are developing a marketing and distribution partnership for the Kensington data mining and visualization suite in the life science domain. The Kensington suite will be offered by Viaken as part of its set of hosted solutions and professional services products. Kensington customers will benefit from Viaken's expertise in the design, deployment, and management of fully integrated end-to-end research informatics solutions.
Kensington is an Internet-based knowledge management platform for the analysis
of life science research data, supporting automated discovery and collaborative
research. The system combines data mining and analytical functions,
visualization tools, collaborative work support, and intellectual property
management functions within an integrated, extensible, and scalable framework.
The system also facilitates the presentation and deployment of scientific
discoveries across a company intranet.
InforSense is an infrastructure software provider for knowledge discovery
and management in the areas of e-science and e-business. InforSense is a
spin-off from the long-established Data Mining Research Group, affiliated to the
Parallel Computing Centre at Imperial College of Science, Technology and
Medicine, London, UK. InforSense's products, the Kensington series, provide
powerful platforms, incorporating a unique combination of a scalable
Internet-based architecture, scalable data mining technology, dynamic knowledge
management and interactive visualization technology, as well as the ability to
develop domain specific
Viaken Systems is the premier end-to-end informatics solutions provider,
offering enabling solutions for biotechnology, pharmaceutical, and agricultural
research and development. Viaken provides a range of informatics solutions
including hosting of research applications and databases, strategic research
informatics services, High Performance Computing, and primary user support to
its customers in the life sciences.
Ad Emmen |
 |